GPLD1 and Parkinson disease: These findings suggest that the anti-inflammatory effects of PLD in LPS-induced PD may be associated with increases in protein levels of p-AKT, p-GSK3βSer9, and Nrf2, as well as decreases in the phosphorylation of NF-κB p65 (Figure 5).